Fennec Pharmaceuticals Inc. (FENC) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 66.88M | 66.56M | 46.02M | 40.79M | 42.98M | 44.12M | 57.97M | 62.17M | 68.17M | 26.86M | 18.95M | 19.33M |
| Cash & Short-Term Investments | 40.18M | 36.72M | 21.93M | 18.7M | 22.68M | 26.63M | 40.32M | 43.05M | 51.18M | 13.27M | 12.4M | 14.96M |
| Cash Only | 40.18M | 36.72M | 21.93M | 18.7M | 22.68M | 26.63M | 40.32M | 43.05M | 51.18M | 13.27M | 12.4M | 14.96M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 18.76M | 23.18M | 19.32M | 17.5M | 15.45M | 12.88M | 12.91M | 12.31M | 10.27M | 8.81M | 4.53M | 2.44M |
| Days Sales Outstanding | 124.92 | 141.91 | 135.93 | 155.33 | 145.69 | 149.71 | 166.35 | 141.51 | 34.22 | 63.03 | 49.21 | 56.49 |
| Inventory | 1.86M | 1.56M | 2.47M | 2.2M | 1.4M | 1.06M | 1.13M | 2.14M | 2.06M | 2.16M | 1.75M | 1.44M |
| Days Inventory Outstanding | 269.85 | 105.27 | 325.87 | 169.63 | 297.27 | 150.24 | 110.81 | 314.91 | 349.11 | 262.64 | 443.88 | 724.62 |
| Other Current Assets | 2.62M | 1.37M | 897.12K | 965K | 1M | 466K | 546K | 283K | 161K | 44K | 20K | 32K |
| Total Non-Current Assets | 4.94M | 3.5M | 3.19M | 4.08M | 3.43M | 822K | 956K | 989K | 1.02M | 6K | 82K | 106K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28.86K | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | 225.74x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 4.25M | 0 | 2.45M | 3.32M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 691K | 3.5M | 742.27K | 760.63K | 3.43M | 822K | 956K | 989K | 1.02M | 6K | 53.14K | 106K |
| Total Assets | 71.82M | 70.07M | 49.21M | 44.88M | 46.4M | 44.95M | 58.92M | 63.16M | 69.19M | 26.86M | 19.03M | 19.44M |
| Asset Turnover | 0.21x | 0.23x | 0.26x | 0.21x | 0.19x | 0.15x | 0.11x | 0.11x | 0.53x | 0.42x | 0.34x | 0.16x |
| Asset Growth % | 54.78% | 55.89% | -16.48% | -28.95% | -32.94% | 67.31% | 209.65% | 224.95% | 217.09% | -0.28% | -37.44% | 24.85% |
| Total Current Liabilities | 9.59M | 10.5M | 9.81M | 8.41M | 8.37M | 6.92M | 7.43M | 7.75M | 9.84M | 7.55M | 3.91M | 3.78M |
| Accounts Payable | 6.28M | 4.63M | 5.86M | 5.94M | 5.28M | 3.24M | 3.87M | 4.45M | 5.2M | 3.78M | 2.94M | 3M |
| Days Payables Outstanding | 861.12 | 273.47 | 822.51 | 527.98 | 1.03K | 488.74 | 281.83 | 722.24 | 743.06 | 451.2 | 826.33 | 1.83K |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 248K | 247.55K | 247.76K | 248K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.06M | 5.62M | 3.7M | 0 | 248K | 248K | 248K | 252K | 252K | 0 | 0 | 0 |
| Current Ratio | 6.98x | 6.34x | 4.69x | 4.85x | 5.13x | 6.38x | 7.80x | 8.02x | 6.93x | 3.56x | 4.84x | 5.12x |
| Quick Ratio | 6.78x | 6.19x | 4.44x | 4.59x | 4.97x | 6.22x | 7.64x | 7.75x | 6.72x | 3.27x | 4.39x | 4.74x |
| Cash Conversion Cycle | -466.35 | -26.29 | -360.71 | -203.03 | -585.05 | -188.79 | -4.67 | -265.82 | -359.72 | -125.54 | -333.24 | -1.05K |
| Total Non-Current Liabilities | 24.56M | 24.52M | 43.9M | 43.92M | 43.91M | 43.9M | 56.66M | 56.77M | 56.34M | 30.93M | 25.65M | 25.39M |
| Long-Term Debt | 0 | 0 | 18.09M | 19.36M | 19.35M | 19.34M | 32.1M | 31.77M | 31.35M | 30.93M | 25.64M | 25.39M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 7K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 24.52M | 1.27M | 0 | 24.56M | 24.56M | 24.56M | 24.99M | 24.99M | 0 | 0 | 0 |
| Total Liabilities | 34.15M | 35.02M | 53.7M | 52.34M | 52.28M | 50.82M | 64.09M | 64.52M | 66.18M | 38.49M | 29.56M | 29.16M |
| Total Debt | 0 | 0 | 18.09M | 19.36M | 19.35M | 19.34M | 32.1M | 31.79M | 31.37M | 30.95M | 25.67M | 25.39M |
| Net Debt | -40.18M | -36.72M | -3.84M | 659K | -3.32M | -7.29M | -8.22M | -11.27M | -19.82M | 17.68M | 13.27M | 10.43M |
| Debt / Equity | - | - | - | - | - | - | - | - | 10.41x | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | 2.17x | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | -1.37x | - | - | - |
| Interest Coverage | 29.71x | -14.20x | -0.09x | -4.15x | -0.95x | -0.68x | -4.60x | -4.23x | 13.41x | -1.93x | -1.18x | -5.08x |
| Total Equity | 37.67M | 35.05M | -4.49M | -7.46M | -5.88M | -5.87M | -5.17M | -1.36M | 3.01M | -11.62M | -10.53M | -9.73M |
| Equity Growth % | 740.73% | 696.92% | 13.22% | -449.96% | -295.09% | 49.48% | 50.9% | 86.05% | 141.07% | -352.39% | -475.84% | -213.89% |
| Book Value per Share | 1.06 | 1.12 | -0.16 | -0.27 | -0.21 | -0.21 | -0.19 | -0.05 | 0.10 | -0.43 | -0.40 | -0.37 |
| Total Shareholders' Equity | 37.67M | 35.05M | -4.49M | -7.46M | -5.88M | -5.87M | -5.17M | -1.36M | 3.01M | -11.62M | -10.53M | -9.73M |
| Common Stock | 191.23M | 189.56M | 147.51M | 146.16M | 145.98M | 145.61M | 145.44M | 145.28M | 144.93M | 144.31M | 143.56M | 143.34M |
| Retained Earnings | -229.22M | -229.36M | -224.42M | -224M | -220.85M | -219.68M | -217.7M | -211.96M | -206.41M | -219.25M | -216.56M | -214.7M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |